We, therefore, evaluated the effects of expressing miR-139-3p, miR-342-5p, miR-543, and miR-6852 on BCR-ABL expression in the K562 CML cell line. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.